Thrasos Innovation, Inc. Company Profile
Thrasos is a private, clinical stage, bio-therapeutics Company focused on the discovery and development of targeted therapies for the prevention and treatment of severe organ failure, with a principle focus on kidney disease. The Companyâs first drug candidates were selected from an extensive inventory of active peptide compounds generated by the Companyâs design technology platform, called Structure Variant Analysis (SVA). Using SVA, Thrasos has pioneered the design of compounds based on the structure of the bone morphogenetic protein (BMP) family to activate the Smad transduction pathway. The resulting peptides have been shown to protect, repair and restore cell and tissue function in the kidney and other organs.
News Articles
[Thrasos Therapeutics] brings in $35mm via its Series C venture round
[Thrasos Therapeutics Inc.] (therapies to prevent and treat severe organ failure) has raised $35mm through its Series C venture round. GlaxoSmithKline PLC’s SROne led (with funds provided by GSK’s...
Thrasos Therapeutics completes $35 million financing round for treatment of acute kidney injury
Thrasos Therapeutics has completed a $35 Million financing for the development of THR-184, its lead product candidate for the treatment of acute kidney injury . The round was led by new investor, SR...
Thrasos Therapeutics Inc. (Montreal, Quebec) raised $35 million in a series C round led by new investor SR One. New investors Advanced Technology Ventures; Fonds de solidarite; Lumira Capital; MP Heal...
Thrasos Therapeutics completes venture financing
Thrasos Therapeutics, Inc.: Series C $35M
Thrasos Therapeutics (Canada), a clinical-stage pharma company focused on acute kidney injury, closed a $35M Series C financing. Participants include SR One, GSK Canada Life Sciences Innovation Fund,...
Thrasos TherapeuticsTM announced that it has completed a $35 Million (U.S.) financing for the development of THR-184, its lead product candidate for the treatment of acute kidney...
Thrasos secures $35M for THR-184 phase II program for acute kidney injury
Thrasos Therapeutics, a Canadian clinical stage biotherapeutics company, has completed a $35 million financing for the development of THR-184, its lead product candidate for the treatment of acute kid...
Thrasos completes $35 Million financing for development of THR-184 against AKI
Thrasos Therapeutics announced that it has completed a $35 Million (U.S.) financing for the development of THR-184, its lead product candidate for the treatment of acute kidney injury (AKI).
Drugs and Medications
Pur-wash [Niagara Pharmaceuticals Inc.]
Pur-Wash Purified Water, 98.3% Ophthalmic Solution Eyewash
Pur-wash [Niagara Pharmaceuticals Inc.]
Pur-Wash
Eyewash station additive concentrate [Niagara Pharmaceuticals Inc.]
EYEWASH STATION ADDITIVE CONCENTRATE
Antiseptic hand sanitizer [Innovation Specialties]
Drug Facts
Bum ease [Wake Innovation, LLC]
Drug Facts
PubMed Articles
Defining rewardable innovation in drug therapy.
Implementing mechanisms for rewarding those who introduce innovative medicinal products requires a definition of 'rewardable innovation'. Here, we propose a definition of innovation with respect to me...
Organizational readiness for innovation in health care: some lessons from the recent literature.
There is no single intervention that will trigger or ensure innovation in health care, as the interaction between the innovation and the context of its introduction is necessarily complex and variable...
Domain recombination: a workhorse for evolutionary innovation.
Although the combination of modular domains within proteins has been proposed as a determining feature of evolutionary innovation and flexibility, direct evidence for this mechanism of evolution has b...
The pioneering work performed in the social sciences on diffusion of innovation can be applied to medical imaging and shed valuable insights as to how innovation is analyzed and adopted within the pop...
Organizational learning is the process of increasing effective organizational activities through knowledge and understanding. Innovation is the creation of any product, service or process, which is ne...
Clinical Trials
Bipolar Research And Innovation Network - BRAIN
To describe the broad spectrum of Bipolar Disorder patients admitted to out-patient and in-patient psychiatric departments in Norway. Include all admitted Bipolar patients both with and wi...
Innovation in Pulmonary Rehabilitation
The purpose of this study is to compare the effect of exercise treatment combined with breathing retraining (a computerized feedback program), with exercise treatment combined with heliox...
The purpose of this study is to compare the bioavailability (the degree to which a drug becomes available in the body after administration) of 3 different pharmaceutical preparations of a...
There have been numerous studies comparing various ACD measurements in phakic eyes,while researches comparing ACD in pseudophakic eyes are less extensive. With the recent popularity of pr...
A Pilot Scheme - Specimen Collection of Health Management Center
Biomedical and biotechnology industry is internationally regarded as the most brilliant star performer of the future. The development of biomedical depends on a high quality academic resea...
Companies
Thrasos TherapeuticsTM is a private, clinical stage, biotherapeutics company focused on the discovery and development of targeted therapies for the prevention and treatment of kid...
Thrasos is a private, clinical stage, bio-therapeutics Company focused on the discovery and development of targeted therapies for the prevention and treatment of severe organ fail...
Thrasos is a private, clinical stage, bio-therapeutics company focused on the discovery and development of targeted therapies for the prevention and treatment of kidney disease. T...
A privately funded biotech start-up We focus on developing cost effective, easy-to-use, re-generable, energy-saving, eco-friendly new tools, kits & reagents or providing unique services for life scien...
Council for American Medical Innovation (CAMI)
The United States faces serious challenges to maintaining its leadership position in innovation. The Council for American Medical Innovation is bringing together leaders in...
More Information about "Thrasos Innovation, Inc." on BioPortfolio
We have published hundreds of Thrasos Innovation, Inc. news stories on BioPortfolio along with dozens of Thrasos Innovation, Inc. Clinical Trials and PubMed Articles about Thrasos Innovation, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Thrasos Innovation, Inc. Companies in our database. You can also find out about relevant Thrasos Innovation, Inc. Drugs and Medications on this site too.
